A large-scale study has revealed that the shingles vaccine, Zostavax, developed by Merck, significantly reduces the risk of death from dementia among older adults....
UPDATE: A groundbreaking study has revealed that Merck’s Zostavax shingles vaccine significantly reduces the risk of death from dementia. Researchers in Wales found that...